CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-18 | Jalota Deepika Chief Development Officer | Grant or award | +95,555 | 125,501 | ||
| 2024-01-18 | Jalota Deepika Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +225,095 | 225,095 | ||
| 2024-01-18 | Carulli Michael Chief Financial Officer | Grant or award | +82,220 | 91,286 | ||
| 2024-01-18 | Carulli Michael Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +204,630 | 204,630 | ||
| 2024-01-18 | Mack David Henry President and CEO | Grant or award | +163,890 | 442,460 | ||
| 2024-01-18 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +519,915 | 519,915 | ||
| 2023-11-22 | ORBIMED ADVISORS LLC 10% owner | Sale | −87,786 | $2.23 | $196K | 0 |
| 2023-11-10 | Mack David Henry President and CEO | Gift | −85,307 | 278,570 | ||
| 2023-11-10 | Mack David Henry President and CEO | Gift | +85,307 | 165,307 | ||
| 2023-10-18 | Mack David Henry President and CEO | Option exercise | +198,407 | $0.53 | $105K | 363,877 |
| 2023-09-15 | Jalota Deepika Chief Development Officer | Sale | −4,104 | $6.62 | $27K | 29,946 |
| 2023-09-15 | Alland Leila Chief Medical Officer | Sale | −6,291 | $6.62 | $42K | 45,909 |
| 2023-08-07 | Mack David Henry President and CEO | Option exercise · Employee Stock Option (right to buy) | −198,407 | 109,459 | ||
| 2023-08-07 | Mack David Henry President and CEO | Option exercise | +85,500 | $0.53 | $45K | 165,470 |
| 2023-08-07 | Mack David Henry President and CEO | Option exercise · Employee Stock Option (right to buy) | −85,500 | 307,866 | ||
| 2023-06-08 | Stelzer Laurie Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | LEVINE ARNOLD J Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | Gallagher Carol Giltner Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | −21,500 | 0 |
Page 4 of 10 · 196 trades